Podcasts about patients

Are you a bonus parent? This one's for you. Listen to "Affirmations for Stepparents."If this episode was helpful and you want to leave a tip, simply go to AffirmationPod.com/TipJarThe sister episode to this one is Episode 432 Reparenting Yourself Please remember on your birthday you can listen to Birthday Affirmations! It's Episode 318 that published on 1-1-21 AffirmationPod.com/BirthdayAffirmations Thinking of one-on-one coaching?Looking to change your mindset and empower yourself to a better you?Sign up for an affirmations coaching session and let's get to work at AffirmationPod.com/Coaching WANT MORE EPISODES LIKE THIS ONE? Episode 307 Healing Affirmations https://AffirmationPod.com/HealingAffirmations Episode 274 Healing Is Possible and I'm Starting to Heal https://AffirmationPod.com/HealingIsPossible Episode 185 Patient with the Process  https://AffirmationPod.com/Patient Episode 39 Affirmations for Parenting Young Children https://AffirmationPod.com/ParentingYoungChildren REVIEWS

The most anticipated annual tradition on Out of Patients returns with the 2025 Holiday Podcast Spectacular starring Matthew's twins Koby and Hannah. Now 15 and a half and deep into sophomore year, the twins deliver another unfiltered year end recap that longtime listeners wait for every December. What began as a novelty in 2018 has become a time capsule of adolescence, parenting, and how fast childhood burns off.This year's recap covers real moments from 2025 A subway ride home with a bloodied face after running full speed into that tree that grows in Brooklyn. Broadway obsessions fueled by James Madison High School's Roundabout Youth Ensemble access, including Chess, & Juliet, Good Night and Good Luck, and Pirates of Penzance holding court on Broadway. A Disneylanmd trip where the Millennium Falcon triggered a full system reboot. A New York Auto Show pilgrimage capped by a Bugatti sighting. All the things.The twins talk school pressure, AP classes, learner permit anxiety, pop culture fixation, musical theater devotion, and the strange clarity that comes with turning 15. The humor stays sharp, the details stay specific, and the passage of time stays undefeated. This episode lands where the show works best: family, honesty, and letting young people speak for themselves.FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the second part of this two-part series, Dr. Shuvro Roy examines the study's findings and their implications for clinical practice moving forward. Show citation: Kim M, Park YH, Song YS, et al. Gait Improvement Following CSF Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study. Neurol Clin Pract. 2025;15(6):e200549. doi:10.1212/CPJ.0000000000200549

In this episode of the Science of Skin podcast, Dr. Ted Lain and Dr. Andrew Alexis discuss Triferatine Cream, a novel fourth-generation retinoid. They explore its mechanism of action, clinical efficacy, and the importance of addressing not only acne lesions but also the psychosocial impacts of acne on patients. The conversation delves into the results of phase three and phase four clinical trials, highlighting Triferatine's effectiveness in treating both acne and post-inflammatory hyperpigmentation. The episode emphasizes the need for dermatologists to consider the entire acne journey and the long-term benefits of retinoid therapy for their patients. To watch this an other episodes, be sure to check out our YouTube page Takeaways: Triferatine is a novel fourth-generation retinoid. It binds preferentially to the RAR gamma receptor, enhancing its efficacy. Triferatine not only treats acne but also improves scarring and pigmentation. Clinical trials show significant efficacy in both facial and truncal acne. The psychosocial impact of acne is profound and long-lasting. Retinoids are foundational in acne treatment regimens. Patients benefit from continued use of retinoids beyond acne clearance. Phase four studies demonstrate Triferatine's effectiveness in reducing atrophic scars. Acne-induced hyperpigmentation is a significant concern that needs addressing. Education about retinoids can improve patient compliance.See omnystudio.com/listener for privacy information.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-465 Overview: Many patients with coronary artery disease take aspirin, but how should clinicians navigate management when an anticoagulant is also needed? In this episode, we review indications for therapy, explore evidence on dual use, and discuss how to counsel patients on balancing cardiovascular benefits with the risks of combination therapy. Episode resource links: Lemesle G, Didier R, Steg PG, et al. Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation. N Engl J Med. Published online August 31, 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2507532 Guest: Alan M. Ehrlich, MD, FAAFP   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Can a year's worth of hard-won ground marketing lessons help you escape inconsistent patient numbers for good?This episode challenges everything you think you know about ground marketing. Michael unpacks why true, sustainable growth isn't about charming scripts or one-off tactics, it's about building an external operating system for your practice. Discover how moving from random “hit or miss” outreach to a structured model transforms conversations into appointments, and appointments into loyal patients. Drawing on a year's worth of lessons, you'll learn how systems, psychology, and the right ecosystems can form the backbone of a repeatable, team-driven patient acquisition process.We go beyond the basics, revealing the psychology that makes potential patients feel genuinely safe and understood, no matter their background or setting, from bustling cities to close-knit small towns. Learn how to turn “no” into valuable data, adapt your strategies to fit your unique local environment, and integrate authentically with community hubs like gyms, schools, or senior centers. Plus, we break down actionable ways to empower your team, assign clear marketing roles, and track your progress so you can become the practice everyone in your area trusts. If you're ready to replace random acts of marketing with a reliable system that builds real authority, this episode is for you!What You'll Learn in This Episode:Why ground marketing is a system, not a handful of sales tactics.How to implement a flywheel approach for consistent patient flow.The psychological foundations of trust and rejection in marketing outreach.Steps to transition from random outreach to repeatable, data-driven processes.How to leverage schools, gyms, and local hubs to grow your practice.Assigning team roles to create accountability and measurable results.Ways to adapt your ground marketing to urban vs. rural environments.Tracking, reviewing, and improving each stage for predictable growth.Turning every patient interaction into a community-building opportunity.Start your journey to sustainable new patient growth with the best lessons we've learned in a year of ground marketing!‍‍Learn More About the Ground Marketing Course Here:Website: https://thedentalmarketer.lpages.co/the-ground-marketing-course-open-enrollment/‍Host: Michael AriasJoin my newsletter: https://thedentalmarketer.lpages.co/newsletter/‍Join this podcast's Facebook Group: The Dental Marketer Society‍Love the Podcast? Let Us Know How We're Doing on Apple Podcasts!

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to⁠ outcomesrocket.com What if AI could not only track your health but truly care for you when your doctor isn't around? In this episode, Dr. Jennie Luna, Founder and CEO of NuVee, discusses creating an AI health companion called Koa, designed to provide empathy and support to patients between doctor visits. She explains the difference between GLP-1 and GIP+GLP-1 medications for diabetes and obesity. Dr. Luna also shares her journey in healthcare, discussing how AI is transforming the industry and the need for more compassionate care in managing chronic conditions, such as obesity. She discusses how technology can bridge the gap in patient care, providing personalized support where it's needed most. Tune in to discover how AI is transforming the future of healthcare and enabling patients to live healthier, more connected lives Resources Connect with and follow Dr. Jennie Luna on LinkedIn. Follow NuVee on LinkedIn and discover their website!

In part one of this two-part series, Dr. Shuvro Roy explains idiopathic normal pressure hydrocephalus (iNPH), its diagnostic challenges, and a study on whether dopamine transporter (DAT) scan results affect gait improvement after a CSF tap test. Show citation: Kim M, Park YH, Song YS, et al. Gait Improvement Following CSF Tap Test in NPH Patients With and Without Striatal Dopaminergic Deficit: A Preliminary Study. Neurol Clin Pract. 2025;15(6):e200549. doi:10.1212/CPJ.0000000000200549

In this episode of SleepTech Talk, we explore how patient involvement is reshaping the diagnosis and treatment of obstructive sleep apnea (OSA).Our guest, Chris Gouveia, MD, is a sleep apnea surgeon and otolaryngologist with training at NIH, Northwestern, and Stanford, currently practicing at Kaiser Permanente.Dr. Gouveia shares why involving patients more deeply in their diagnosis and therapy leads to better outcomes — and how offering multiple treatment pathways can dramatically improve the patient journey.We also take a forward-looking view at the future of sleep medicine, including how OSA diagnosis and therapy are evolving beyond a one-size-fits-all approach.⭐ In this episode, we discuss:Why patient engagement is critical in sleep apnea careHow shared decision-making improves adherence and outcomesExpanding therapy options beyond traditional CPAPThe role of surgery, technology, and personalized care in OSAWhat the future holds for sleep apnea diagnosis and treatmentDr. Gouveia is also the author of Night Shift, a Substack focused on sleep health and medicine, where he explores clinical insights and evolving trends in sleep care.This episode is essential listening for clinicians, sleep professionals, and patients who want to understand where sleep apnea care is headed next.ABOUT SLEEPTECH TALKSleepTech Talk brings together leaders in sleep medicine, technology, and innovation to explore the tools and trends shaping the future of sleep health.Catch the show on most podcast platforms or on YouTubewww.youtube.com/@sleeptechtalk A huge thanks to our sponsors:Medbridge Healthcare  : For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 114The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

The FiltrateJoel Topf‍ ‍@kidneyboy.bsky.social‬ (COI)Sophia Ambruso @sophia-kidney.bsky.socialSwapnil Hiremath @hswapnil.medsky.social and on LinkedInSpecial Guests Jonathan Barratt Professor of Renal Medicine, University of Leicester Google Scholar (COI: all the companies)Editing and Show Notes byNayan Arora @captainchloride.bsky.socialThe Kidney Connection written and performed by Tim YauShow NotesProteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy (Aliza Thompson, 2019 PubMed)The number, quality, and coverage of randomized controlled trials in nephrology (PubMed 2004)A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction (PubMed 2017)BLISS Belimumab in lupus nephritis (NephJC | PubMed)The Phase 2 trial of atacicept A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy (PubMed)The phase 3 trial of atacicept, the subject of this podcast A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy (PubMed | NephJC)The use of Gd-IgA1 in the Testing Trial Role of Systemic Glucocorticoids in Reducing IgA and Galactose-Deficient IgA1 Levels in IgA Nephropathy (PubMed)If you can't get enough Jon Barratt, take a look at his grand rounds at The University of Ottawa. Updates to the KDIGO Guidelines for the treatment of IgA nephropathy, with Prof Jonathan Barratt (YouTube)Tubular SecretionSwapnil Hiremath Pluribus on Apple TV (Wikipedia)Jon Barratt Lynyrd Skynyrd (Wikipedia) Slow Horses (Wikipedia) on AppleTVJoel Topf the new ASN

Texas State Meet. The 3200 meters. One plan. One chance.Rowan Saacke executed.The Bridgeland High School senior from Cypress, Texas spent the past year learning how to stay steady when the stakes were highest. Patient in her approach. Grounded in her training. Oriented toward the team more than the spotlight.Her junior year, the breakthrough came at the Texas state meet. Rowan controlled the 3200m from the start and won the Texas 6A state title. Later that day, she returned for the 1600m and finished 4th. Not a failure. Just a reminder that success doesn't always arrive cleanly. The momentum carried into late May, where she placed 3rd in the mile at RunningLane and ran 4:45 for 11th at the HOKA Festival of Miles, placing herself firmly among the country's top high school distance runners.Cross country added a final layer. In her last season wearing a high school uniform, Rowan helped lead Bridgeland to a Texas 6A state championship, breaking the state meet scoring record with the lowest total in history. Individually, illness complicated the postseason. She finished 5th at state and 19th at NXR South, but helped her team place 2nd and qualify for Nike Cross Nationals.This episode is about composure. About learning to value execution over outcome, and meaning over medals. Rowan reflects on change, pressure, illness, and what it looks like to choose the team when individual goals don't go as planned.If you enjoyed the episode, consider following The Sunday Shakeout on Spotify and Apple Podcasts and leaving a five-star review. It's one of the best ways to support the show.

This episode turns the microphone toward Gil Bashe, host of Health UnaBASHEd, to discuss Gil's soon to be released (est. December 2025) book titled ""Healing the Sick Care System: Why People Matter - Gil Bashe on Restoring Humanity, Trust, and Mission to American Healthcare"". Executive producer and occasional co-host Gregg Masters interviews Gil in a deeply personal conversation about the state of American healthcare, the importance of human-centered care, and what we can learn from Gil's lifelong journey in medicine, policy, advocacy, and spiritual leadership. KEY TOPICS: • Why the U.S. healthcare system struggles • Hyper-specialization and loss of whole-person care • Innovation without access • Patients caught in systemic gaps • Gil's life journey — combat medic, advocate, CEO, rabbi To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Your life should be at risk before you let them touch you.Support the show

Guests: Captain James Fanell (USN Ret.) and Bradley Thayer. Fanell argues the U.S. must "admit failure" regarding China, likening the situation to a patient acknowledging cancer to begin treatment. To combat "threat deflation" and institutional bias in intelligence, they propose a "Team B" of independent analysts to objectively assess PRC capabilities. Thayer advocates moving oversight of foreign investment (CFIUS) to the Department of Defense and ultimately cutting off all trade to deny the CCP resources and protect intellectual property.

Police Addicted to Drugs And His Amazing Recovery, Special Episode. Police Officer Attacked, Multiple Surgeries, Forced Retirement, Addiction, and an Inspiring Recovery. This special episode is streaming for free on the Law Enforcement Talk Radio Show and Podcast website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform Brock Bevell never imagined that a single violent moment would change the entire trajectory of his life. A retired Mesa, Arizona police officer, Brock dedicated his career to public service, until a targeted act of violence ended his time on the job and set him on a painful, unexpected journey through addiction and recovery. Look for The Law Enforcement Talk Radio Show and Podcast on social media like their Facebook , Instagram , LinkedIn , Medium and other social media platforms. “She threw the truck into reverse and hit me,” Brock recalls. “In an instant, everything changed.” Supporting articles about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . A Career Cut Short by Violence While serving with the Mesa Police Department, Brock was seriously injured during a violent incident involving a vehicle. The attack caused devastating, career-ending injuries and required multiple surgeries. What followed was a long and grueling rehabilitation process, one familiar to many injured officers across the country. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Available for free on their website and streaming on Apple Podcasts, Spotify, Youtube and other podcast platforms. To manage the intense pain, Brock was prescribed opioid pain medication. Like countless patients recovering from serious injuries, he trusted the prescriptions meant to help him heal. Instead, they quietly became the beginning of a much deeper struggle. From Recovery to Addiction During months of surgeries and physical therapy, Brock developed a severe dependence on opioid painkillers. What started as medically prescribed relief slowly evolved into addiction. “I didn't recognize myself anymore,” Brock says. “My world became smaller and darker. I was surviving, not living.” Brock openly shares how addiction affected every part of his life, his relationships, his identity, and his sense of purpose after forced retirement from policing. His story reflects a reality many first responders face but few openly discuss. Police Addicted to Drugs And His Amazing Recovery, Special Episode. The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. The Science Behind the Crisis Research underscores just how common Brock's experience is. A major study published in JAMA Internal Medicine by researchers at the Stanford University School of Medicine found that patients undergoing 11 common surgeries faced an increased risk of becoming chronic opioid users. Lead author Eric Sun, MD, PhD, explained: “For a lot of surgeries, there is a higher chance of getting hooked on painkillers.” The study defined chronic opioid use as filling 10 or more prescriptions or receiving more than a 120-day supply within a year after surgery. Patients undergoing knee surgery faced the highest risk, nearly five times that of nonsurgical patients, followed by gallbladder surgery. Importantly, the study did not suggest avoiding surgery, but emphasized the need for careful monitoring and alternative pain management strategies. Police Addicted to Drugs And His Amazing Recovery, Special Episode. The interview can be found on The Law Enforcement Talk Radio Show and Podcast website, on Apple podcasts, Spotify, Youtube and on LinkedIn, Facebook, Instagram, and across most podcast platforms where listeners will find authentic law enforcement stories. Trauma, Policing, and Substance Use Law enforcement officers face unique occupational hazards, including repeated exposure to trauma. Studies show that substance use disorders, including alcohol and drug dependence, occur at higher rates among officers, particularly those experiencing psychological distress. In nationally representative data, more than half of men with lifetime PTSD also had a history of alcohol abuse or dependence. For police officers, these risks are compounded by work stress, injuries, and the cultural stigma surrounding mental health and asking for help. “We wear the uniform, but we're human,” Brock says. “And sometimes the damage doesn't show until it's almost too late.” The full podcast episode is streaming now on their website, on Apple Podcasts, Spotify, Youtube and across Facebook, Instagram, and LinkedIn. Hitting Bottom and Choosing Recovery Brock's turning point came when he realized addiction had taken everything it could from him. With professional help, support, and unwavering determination, he entered recovery and committed to sobriety. “Recovery didn't give me my old life back,” he says. “It gave me a new one, one with purpose.” Police Addicted to Drugs And His Amazing Recovery, Special Episode. Today, Brock uses his experience to help others struggling with addiction, trauma, and life after law enforcement. His message is clear: recovery is possible, even after profound loss. Healing Beyond the Badge In the aftermath of violence and trauma, communities often look to police officers as symbols of strength. Yet officers themselves must also heal. Proactive wellness programs, mental health resources, and open conversations about addiction are critical, not just for officers, but for the communities they serve. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Mesa, located just east of Phoenix, is known for its deep history, from the ancient Hohokam culture to the modern city Brock once patrolled. It is also where his story originated, one of resilience, accountability, and hope. Listen to Brock's Story Brock Bevell's journey is featured in this Special Episode of the Law Enforcement Talk Radio Show and Podcast available for free on their website, also on Platforms like Apple Podcasts, Spotify, YouTube and most major podcast platforms. His story is also being shared across their Facebook, Instagram, LinkedIn, and other Social Media and News outlets. Listen to Brock's inspiring account of what happened, how prescribed opioids led to addiction, and how recovery helped him rebuild his life, and helps others do the same. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Because sometimes, the most powerful stories of policing aren't about arrests or badges, but about survival, healing, and redemption. You can help contribute money to make the Gunrunner Movie . The film that Hollywood won't touch. It is about a now Retired Police Officer that was shot 6 times while investigating Gunrunning. He died 3 times during Medical treatment and was resuscitated. You can join the fight by giving a monetary “gift” to help ensure the making of his film at agunrunnerfilm.com . Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . Stay connected with updates and future episodes by following the show on Facebook, Instagram, LinkedIn, their website and other Social Media Platforms. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. Be sure to check out our website . Be sure to follow us on X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. Listeners can tune in on the Law Enforcement Talk Radio Show website, on Apple Podcasts, Spotify, YouTube, and most every major Podcast platform and follow updates on Facebook, Instagram, and other major News outlets. You can find the show on Facebook, Instagram, Pinterest, X (formerly Twitter), and LinkedIn, as well as read companion articles and updates on Medium, Blogspot, YouTube, and even IMDB. Police Addicted to Drugs And His Amazing Recovery, Special Episode. Attributions Stanford Medical IACP NIH Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Are you seeing more patients than ever but wondering where all the money is going? You might be caught in the revenue trap.  In this candid SNACK episode, Miranda turns the mic on Tracy to explore why practice growth doesn't always translate to better profit margins or more freedom. Many healthcare practice owners are busier than ever—maybe even adding providers or locations—but when they look at their actual take-home numbers, something doesn't add up.  Tracy shares a real client story about how being "too busy" to look at the books led to a simple system glitch costing thousands per month. She also breaks down what practice owners need to audit before considering expansion, why trading time for dollars has a ceiling, and how to know if growth is actually serving your goals.  Whether you're considering adding another provider, opening a second location, or just trying to understand why you're working harder but not seeing the financial rewards, this episode will help you think differently about practice profitability.  Is your practice growth-ready? See Where Your Practice Stands: Take our Practice Growth Readiness Assessment  Read the full show notes, memorable quotes, and key takeaways.  Key topics include:  The first question to ask before pursuing growth  Why efficient systems matter more than patient volume  What to evaluate before opening a second location  How to escape the time-for-money trap  Read the full show notes, memorable quotes, and key takeaways. 

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Pre-Order linkaChart, for free: https://linkachart.ai/?utm_term=ryan2Free AI Community: https://www.skool.com/simple-ai-2158/about?ref=39d2b08dc94f4d2a8d9c5a75b3dbd2bbSign up for Neuralink's clinical trials: https://neuralink.com/trials/Work at Neuralink: https://neuralink.com/careers/How Neuralink will solve paralysis: https://youtu.be/X3aUqYAnAk4?si=mJOg6cp6zbWkjjQoNeuralink's Medical Affairs Lead: https://neuralink.com/updates/welcome-david-mcmullen/20 patients: https://www.neurapod.com/blog/neuralink-advances-toward-goal-of-20-implants-by-2026- Jon Noble, P18, GB-5: https://x.com/CheckCanopy/status/1999724602663010635?s=20- Noland Arbaugh Post: https://x.com/ModdedQuad/status/1991276567377363419?s=20- 10-finger typing: https://x.com/neuralink/status/1999148500878012773?s=20- David McMullen: https://x.com/NeuraPod/status/1998597644667732205?s=20- New construction: https://x.com/SERobinsonJr/status/1998552391428284480- DJ Seo presentation at UT Austin: https://x.com/neuralink/status/1996278331541733773?s=20- Actual implant: https://x.com/RockyNoHands/status/1988658122462732371?s=20- Patient's Gaming: https://x.com/XFreeze/status/1995895047834009873?s=20- Alex Conley: https://x.com/Bcidesign/status/1987319669556998377?s=20- Rob Greiner video gaming: 00:38 - 01:28: https://x.com/greiner_ro52817/status/1993511793948606532?s=20- Post from Elon: https://x.com/elonmusk/status/1987884162167300589?s=20- Competitor: Paradromics announcement: https://www.linkedin.com/posts/matt-angle_neurotech-bci-paradromics-activity-7397295753980776448-3FEX/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAzs9VsBCL4IjyCpvAz3a8tfBfuzIkoFEbsNeura Pod is a series covering topics related to Neuralink, Inc. Topics such as brain-machine interfaces, brain injuries, and artificial intelligence will be explored. Host Ryan Tanaka synthesizes information, shares the latest updates, and conducts interviews to easily learn about Neuralink and its future.Follow on X: https://www.x.com/neurapod/Generate AI voice audio via ElevenLabs: https://try.elevenlabs.io/xe894d3yv35hOpinions are my own. Neura Pod receives no compensation from Neuralink and has no formal affiliation to the company. Ryan Tanaka may have an equity stake in Tesla, Neuralink, or any of Elon Musk's companies.#Neuralink #ElonMusk #Tesla

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KGS865. CME credit will be available until December 21, 2026.Elevating Total Care for PV and ET: From Diagnostic Precision to Patient-Centred Innovation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Olivier Soubrane est un très grand chirurgien qui a pris le temps de venir nous parler de sa vie et dont la pudeur et l'humilité nous obligent. Passionné par son métier, Olivier Soubrane consacre sa vie à sauver les nôtres. Très impressionnée par cet homme, j'en ai oublié ma retenue légendaire (!!) et allez comprendre pourquoi, j'ai raconté ma vie... j'espère que vous ne m'en voudrez pas. Mais l'essentiel est ailleurs. Alors le gout de la médecine et cette envie de faire de la chirurgie, la différence entre les médecins d'hier et ceux d'aujourd'hui, mais aussi ce qui le rend le plus heureux et le plus fier ou encore sa relation aux patients, la réaction hospitalière lors du COVID et ses plus grands souvenirs de chirurgie, tout cela et bien plus encore c'est à découvrir dans cet épisode. Le dernier de l'année donc...Merci de votre fidélité et de votre soutien. A bientôtJuliaGénérique composé par Jean ThéveninHébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this special festive episode of “How Do You Say That?!” sponsored by britishvoiceover.co.uk, Katy Maw and Phil Rowe join Sam and Mark for a right-old Christmas knees-up. As it's Boxing Day - there are four boxes stuffed with seasonal audio goodies! Of course, there are also four scripts, full of festive goodness... and some wildcards too!This episode is also entirely on video - only the second one we've done this way, so you can watch it on YouTube as well: https://youtu.be/WVclGe-xKaEGet involved! Have you got a Wildcard suggestion that we should try or an idea for the show? Send it to us via Mark or Sam's social media or email it directly to podcast@britishvoiceover.co.ukScript 1Cassandra made a great start in secondary school this year. Better than we could have hoped for. Her number one sport continues to be water polo. She also joined the school concert band and jazz band. She has made a lot of friends and is popular in her year.Jacqui manages to train as a surgeon while fitting in diving trips to Thailand, Cayman, Cuba and the Red Sea. We've told you about Tori's sporting prowess, and at number 5 in the world, she is not doing badly! The boys have a hamster.Script 2It was snowing. It was always snowing at Christmas. December, in my memory, is white as Lapland, although there were no reindeers. But there were cats. Patient, cold and callous, our hands wrapped in socks, we waited to snowball the cats. Sleek and long as jaguars and horrible-whiskered, spitting and snarling, they would slide and sidle over the white back-garden walls, and the lynx-eyed hunters, Jim and I, fur-capped and moccasined trappers from Hudson Bay, off Mumbles Road, would hurl our deadly snowballs at the green of their eyes.Script 311 a.m. Office. Oh my God. Daniel Cleaver just sent me a message. Message Jones: You appear to have forgotten your skirt. As I think is made perfectly clear in your contract of employment, staff are expected to be fully dressed at all times. CleaveHah! Undeniably flirtatious. Have never messaged Daniel Cleaver before but brilliant thing about messaging system is you can be really quite cheeky and informal, even to your boss. Also can spend ages practising. This is what I sent:Script 4The finger pointed from the grave to him, and back again."No, Spirit! Oh no, no!"The finger still was there."Spirit!" he cried, tight clutching at its robe, "hear me!I am not the man I was. I will not be the man I must have been but for this intercourse. Why show me this, if I am past all hope!"For the first time the hand appeared to shake.We'd love your feedback - and if you listen on Apple Podcasts or Spotify, hit the follow button today!**Listen to all of our podcasts here - you can also watch on YouTube, or say to your smart speaker "Play How Do You Say That?!"About our guests: Katy Maw has been voicing for about a quarter of a century after becoming a classically trained actor in London. She works daily, predominantly on corporate & commercial scripts & has voiced literally thousands of local & National radio ads over the years and she works across all other mediums of voicing, like e-learning and...

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/KGS865. CME credit will be available until December 21, 2026.Elevating Total Care for PV and ET: From Diagnostic Precision to Patient-Centred Innovation In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

Three children were killed in a house fire in Jackson County, Kentucky, over the holiday. Another child was taken to a hospital in Ohio. The death toll from last month's crash of a cargo jet in Louisville has risen. Patients with a rare form of A-L-S may finally have new hope...in some cases, reverse the symptoms. See omnystudio.com/listener for privacy information.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning discusses how to get involved with Pace4Life, a charity he supports that provides reconditioned pacemakers to Ghana. He also previews upcoming podcast episodes and guests, including discussions on the Ross procedure guidelines and more interviews related to the JCOG0802 trial.  Chapters 00:00 Intro  02:31 JANS 1, Ethiopian Surgeon  07:08 JANS 2, RCA to Cor Sinus Fistula  09:30 JANS 3, Y-Incision Hemodynamics  12:38 JANS 4, Endograft Infection  15:06 Instructional Video Competition  16:01 Career Center  16:40 Video 1, Complications Podcast  19:34 Video 2, Totally Endoscopic Case  21:23 Video 3, Post-Infarction VSD Repair  23:15 Closing, Upcoming Events  Joel also highlights recent JANS articles on a heart surgeon who saved another surgeon's life as a teen and how they now perform surgeries together, right coronary artery to coronary sinus fistula, a surgical aortic valve replacement with Y-incision aortic annular enlargement provided better hemodynamics than transcatheter aortic valve replacement, and management of endograft infection after thoracic endovascular aortic repair.  In addition, Joel explores totally endoscopic mitral and tricuspid valve repair, ASD with APVR repair, and LAA occlusion, as well as the repair of a post-infarction VSD, and an episode of The Atrium podcast featuring host Dr. Alice Copperwheat speaking with Dr. Samer Nashef about complications in cardiothoracic surgery. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.)  A Heart Surgeon Saved His Life as a Teen. Now They Perform Surgeries Together.  2.) Right Coronary Artery to Coronary Sinus Fistula: A Rare Problem With an Elegant Solution  3.) Surgical Aortic Valve Replacement With Y-incision Aortic Annular Enlargement Provided Better Hemodynamics Than Transcatheter Aortic Valve Replacement  4.) Management of Endograft Infection After Thoracic Endovascular Aortic Repair  CTSNet Content Mentioned  1.) The Atrium: Complications  2.) Totally Endoscopic Mitral and Tricuspid Valve Repair, ASD With APVR Repair, and LAA Occlusion  3.) Repair of a Post-Infarction VSD  Other Items Mentioned  1.) Pace4Life   2.) MICS and Robotic-Assisted Surgery: A Roundtable Discussion With the Endoscopic Cardiac Surgeons Club  3.) Instructional Video Competition  4.) 2025 CTSNet Recruitment Guide   5.) Career Center   6.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/MYA865. CME/MOC/AAPA/IPCE credit will be available until December 8, 2026.Hypertrophic Cardiomyopathy Care in the CMI Era: Elevating Outcomes With Cardiac Myosin Inhibitors In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE information, and to apply for credit, please visit us at PeerView.com/UAH865. CME/MOC/NCPD/AAPA/ASWB-ACE/APA/IPCE credit will be available until December 13, 2026.Remembering Brain Health: Targeting Modifiable Risk Factors and Early Detection of Cognitive Symptoms to Reduce the Burden of Dementia In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and BrightFocus Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

CardioNerds (Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Natalie Marrero) discuss anti-arrhythmic drugs in the management of atrial fibrillation and atrial flutter with electrophysiologist Dr. Andrew Epstein. We discuss two major classes of anti-arrhythmic drugs, class IC and class III, as well as digoxin. Dr. Epstein explains their mechanisms of action, indications and specific patient populations in which they would be particularly helpful, efficacy, adverse side effects, contraindications, and key drug-drug interactions. We also elaborate on defining clinical trials and their clinical implications. Given the large burden of atrial fibrillation and atrial flutter in our patient population and the high prevalence of anti-arrhythmic drug use, this episode is sure to be applicable to many practicing physicians and trainees. Audio editing by CardioNerds academy intern, Grace Qiu.  Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls Anti-arrhythmic drugs should not be thought of as an alternative to ablation but, instead, should be considered an adjunct to catheter ablation.   Class IC anti-arrhythmic drugs, flecainide and propafenone, are highly efficacious for acute cardioversion and a great option for patients with infrequent episodes of AF who do not have a history of ischemic heart disease.    Class III anti-arrhythmic drugs like ibutilide, sotalol, and dofetilide, are highly effective for acute conversion; however, they require hospitalization for close monitoring during initiation and dose titration given the risk of prolonged QT.   Amiodarone should not be used as a first line agent given its toxicities, prolonged half-life, large volume of distribution, and drug-drug interactions.   Dr. Epstein notes that, “All drugs are poisons with a few beneficial side effects,” when highlighting the many adverse side effects of anti-arrhythmic drugs, particularly amiodarone, and the importance of balancing their benefit in rhythm control with their side effect profile.   Notes Notes: Notes drafted by Dr. Natalie Marrero. What are the Class IC anti-arrhythmic drugs and what indications exist for their use?   Class IC anti-arrhythmic drugs are anti-arrhythmic drugs that work by blocking sodium channels and, thereby, prolonging depolarizing.   Class IC anti-arrhythmic drugs include flecainide and propafenone.   Class IC anti-arrhythmic drugs are good agents to use in patients that have infrequent episodes of AF and do not want daily dosing as these agents can be used by patients when they feel palpitations and desire acute conversion back to sinus rhythm (“pill in the pocket” approach).    What are the adverse consequences and/or contraindications to using a class IC agent?  Class IC anti-arrhythmic agents are contraindicated in patients with a history of ischemic heart disease based on increased mortality associated with their use in these patients in the CAST trial.   Given the results of the CAST trial, providers should screen annually for ischemia via a functional stress test in patients on these drugs at risk for coronary disease.   These drugs can increase 1:1 conduction of atrial flutter and, therefore, require concomitant use of a beta blocker.   These agents are generally well-tolerated without any organ toxicities; however, they can precipitate heart failure in patients with cardiomyopathies, cause sinus node depression, and unmask genetic arrythmias such as a Brugada pattern.   What are the class III agents and what are indications for their use?   Class III agents are drugs that block the potassium channel, prolonging the QT, and include Ibutilide, Sotalol, and Dofetilide.    Class III agents can be considered in patients with or without a history of ischemic heart disease that desire effective acute chemical cardioversion and are willing to go to the hospital for close monitoring during dose initiation and titration.   Other specific circumstances in which one can use these agents, specifically Ibutilide, are in patients with recurrent atrial fibrillation and Wolf Parkinson White (due to slowed conduction via the accessory pathway).  What are the adverse consequences and/or contraindications to using a class III agent?  Ibutilide, Sotalol, and Dofetilide prolong the QT and increase the risk of torsade de pointes, which is why they require ECG monitoring in-patient during drug initiation and dose titration.    These agents are generally well-tolerated.   Sotalol should be avoided or used cautiously in patients with left ventricular dysfunction, while dofetilide can be used and has dose-response beneficial effects in patients with left ventricular dysfunction.   Both sotalol and dofetilide are renally cleared with specific creatinine clearance cutoffs (CrCl < 20 for dofetilide and CrCl

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

“We get a lot of inappropriate over-prescribing for almost everything,” says drug policy researcher and journalist Alan Cassels.Cassels is the co-author of “Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients.”For Cassels, it was one disease in particular—osteoporosis—that changed his entire view of medicine.Based on changing definitions of the disease, large swaths of Americans could suddenly be declared sick and in urgent need of drug treatment.They “medicalized normal aging of basically the entire female population. Overnight,” he says.In our interview, we discuss the influence of the pharmaceutical industry on overdiagnoses and prescriptions, and how the criteria for many diseases can be expanded arbitrarily.“When you look closely at the quality of prescribing, a lot of times, the decision-making is not really driven by evidence. It's driven mostly by … marketing, biases, influence from thought leaders, and influence from guidelines, medical guidelines themselves, which are often appallingly biased,” he says.Many doctors, Cassels says, know little about the adverse effects of the many drugs they prescribe to their patients.We also dive into the connection between psychiatric drug prescriptions and violence, how psychiatry labels normal behaviors as abnormal, and how exaggerated statistics are used to sell theories of disease and drug treatments.Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

In this game-changing podcast episode host Jesse Ewell interviews Dr. Jamie West, a chiropractor turned functional medicine practitioner. They discuss Jamie's journey into functional medicine, the resistance she faced in incorporating new methods, and the transformative results her patients have experienced through a new weight loss program. The conversation highlights the shift from one-on-one patient care to a scalable model, the importance of effective marketing, and the financial success that has followed. Jamie shares personal insights on her own health transformation and offers advice for other practitioners considering similar paths. Dr. Jamie West transitioned from chiropractic to functional medicine. Resistance to new methods often stems from lack of research. Peptides can significantly aid in healing and weight loss. Patients experience rapid improvements, such as reduced brain fog. The program allows for scalable patient care without sacrificing results. Effective marketing builds confidence and trust in practitioners. Perfect for entrepreneurs, small business owners, and anyone looking to scale their business through social media. Click the link below and learn how Jesse and his team can help you achieve similar transformative results. To find out more about the VIP weight loss system email me directly or reach out on socila media. Learn more about Jesse though the following links: VIP WEIGHT LOSS SYSTEM HBL Lifestyle Secrets Group on Facebook Personal Website HBL Website Instagram Email  

This is a re-release celebrating a decade of love and allyship on A Gay And A NonGay. This week we're throwing it back to May 2020... We've heard about 'expendable' populations before, but last time they meant gay people. 32 million people have died of AIDS related illnesses since the 1980s and in 2018, 770,000 people died worldwide because of the virus. The London Patient: A Cure For HIV? is the first episode in a brand new two-part series - funded by the Wellcome Trust and the British Podcast Awards Fund. Both episodes were recorded in accordance with government social distancing measures. On this episode, we look at the start of the epidemic, chat to AIDS activist Sir Nick Partridge OBE and head to Oxford to meet Professor John Frater who explains the science behind HIV. Trigger warning: Contains upsetting audio. Incredible advances in medicine now mean that if you are HIV+ and on effective treatment, you can't pass it on. Undetectable = Untransmittable. And in March 2019, it was revealed that a second person had been cured of HIV - The London Patient. What does the London Patient's story tell us about a cure for HIV? Plus in the age of Covid19, can the story of HIV and AIDS offer the world any hope? This episode is bought to you with thanks to the ⁠MTV Staying Alive Foundation⁠, the ⁠Terrence Higgins Trust⁠ and the ⁠National AIDS Trust⁠. Follow A Gay & A NonGay TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@gaynongay⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠gaynongay.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email Us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠us@gaynongay.com⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Like the episode? Let us know with a quick text!In this episode, Allison interviews Becca Pizzi, an accomplished runner and Ironman world champion.Becca shares insights into her running journey, starting from her childhood in Belmont, Massachusetts, to achieving world records and running marathons on all seven continents.She discusses her experiences in various races, including the World Marathon Challenge and the Kona Ironman World Championship.Becca also talks about her contributions to the running community, such as organizing a local 5K in Belmont and authoring a children's book.She emphasizes the importance of community support, maintaining determination, and setting goals, regardless of their scale.Becca Pizzi - https://www.facebook.com/beccapizzihttps://beccapizzi.com/Races MentionedNorth Pole MarathonWorld Marathon ChallengeBoston MarathonLondon MarathonShanghai MarathonShout OutsSteven PlakasSeanOliver WangTeam HoytSupport the showFor more details on Run Your Story happenings, visit https://runyourstory.com/For web development or tech services, visit https://gaillardts.com/Go Run Your Story and take a piece of this story with you! Follow us on Facebook and Instagram for the latest news on upcoming episodes. Support me on Patreon!Can't wait to hear Your Run Story!! Thank you to all of our Patreon supporters!Kristen RatherSteve TaylorMary TrufantSuzanne CristSuzanne ClarkAnna SzymanskiDave McDonaldKarla McInnisJames ContrattoJordan DuBoseCristy EvansSharonda ShulaNell GustavsonMeredith NationsAllyson SwannChris StrayhornKaren SaldivarStefan ClaytonRachael McRaeScott Thornhill

This year's biggest patient access wins didn't come from trend decks or theoretical frameworks — they came from listening. In this episode, we share the patterns Infinx heard repeatedly across calls with our clients, and what those signals revealed about what actually moved the needle in patient access.

A man is haunted from childhood by a recurring, deeply unsettling dream in which he always finds himself visiting the same gloomy house, meeting the same strange family, and being led toward a particular room at the top of the house. As the years pass, the dream evolves in disturbing ways. This original recording is an audio presentation by Jasper L'Estrange for EnCrypted Horror. “THE ROOM IN THE TOWER” by E. F. Benson, 1912.Happy Christmas and New Year everybody! See you in 2026!

How Did H2O Innovation Build a Water Empire Through 18+ Acquisitions (M&A) and What Happens Now Under Private Equity?More #water insights? Get my free mapping of 267 water investors here: https://investors.dww.show

If your clients aren't rebooking consistently, it's not a motivation problem… it's a systems problem. In this episode, I'm sharing a replay of a live training I taught in partnership with GlossGenius, where I broke down the 3 pillars of transformational client loyalty. We dive into how to move clients from one off appointments into long-term commitments, restructuring your menu around outcomes, and building an automated retention engine that works behind the scenes. I also share the CARES consultation framework, how to design a multi-million dollar menu built around solutions instead of services, and how automation can become your partner in driving rebooking, renewals, and long-term loyalty. Get ready to stop chasing rebookings and start leading with systems that make loyalty inevitable.   HIGHLIGHTS The 3 pillars of transformational client loyalty. Why most consultations fail to create long-term commitment. The CARES framework that turns consults into annual plans. The sales psychology technique that increases plan and package buy-in. Automation is your partner in retention and rebooking.   RESOURCES + LINKS Sign up to get a 2-week FREE trial of GlossGenius HERE Try Ask Heather AI for 30 Days HERE Apply for The Med Spa Advantage HERE   FOLLOW Heather: @heatherterveen Website: heatherterveen.com

Jason Gilley walked into adulthood with a fastball, a college roster spot, and a head of curls that deserved its own agent. Cancer crashed that party and took him on a tour of chemo chairs, pediatric wards, metal taste, numb legs, PTSD, and the kind of late night panic that rewires a kid before he even knows who he is.I sat with him in the studio and heard a story I know in my bones. He grew up fast. He learned how to stare down mortality at nineteen. He found anchors in baseball, therapy, and the strange friendships cancer hands you when it tears your plans apart. He owns the fear and the humor without slogans or shortcuts. Listeners will meet a young man who refuses to let cancer shrink his world. He fights for the life he wants. He names the truth without apology. He reminds us that survivorship stays messy and sacred at the same time. This conversation will stay with you.RELATED LINKS• Jason Gilley on IG• Athletek Baseball Podcast• EMDR information• Children's Healthcare of AtlantaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

 Sandra and Greg Mundis are the resilient couple behind the inspirational real-life account, “Patient Number One: Embracing Hope in Times of Despair.” Greg, a global leader as Executive Director of Assemblies of God World Mission, and Sandra, a gifted storyteller and founder of Europe's Children ministry, have spent decades impacting lives across 195 countries. Their new book chronicles Greg's harrowing journey as the first COVID-19 intubation patient at his hospital—given little chance to live—and Sandra's fierce faith-fueled advocacy, demonstrating the miraculous power of hope, family, and community in the darkest times. In this episode of Marketer of the Day, Sandra and Greg join Robert Plank to share their journey from devastation to hope. They candidly detail Greg's critical illness, the emotional and physical ordeal of prolonged hospitalization and rehabilitation, Sandra's steadfast persistence, and the profound role faith and global prayer played in recovery. The conversation highlights themes of family unity, the psychological toll of crisis, finding purpose beyond suffering, and the decision to turn their collective trauma into a published story of inspiration. Listeners will learn about the importance of documenting miracles, building a support network, and how adversity can lead to deeper connection and renewed mission. Quotes: “If it wasn't for Jesus, I wouldn't be sitting here talking to you.” “God's word was like my food... There's power in those words, and it truly brought me through.” “If I take him home, it's the best thing I can do for him... But if I leave him, I want to receive the glory.” Resources: Buy “Patient Number One” on Amazon. Learn more about how they turn challenges into opportunities for change on their website Follow  Sandra and Greg Mundis on Facebook

When we think of potentially dangerous and addictive drugs, most of us think about illegal substances like heroine or cocaine. And yet widely-prescribed drugs like Xanax, Ritalin, Adderall, and Vicodin are also addictive, but legal in the United States. Historian David Herzberg discusses the artificial distinction that has been created between addictive drugs and medicines — with the key difference being the class and race of the consumers who use them and the partial protections that one group receives and the other does not. (Encore presentation.) David Herzberg, White Market Drugs: Big Pharma and the Hidden History of Addiction in America University of Chicago Press, 2020 The post Good Patients, Bad Addicts appeared first on KPFA.

Is IVF the answer for recurrent pregnancy loss? Why would IVF with genetic testing of embryo be helpful for people that are 'getting' pregnant but can 'stay' pregnant?  In this educational episode, Dr. Lora Shahine explains the complex relationship between IVF, genetics, and recurrent pregnancy loss. She reviews the science behind why chromosomal imbalances are one of the most common causes of first-trimester miscarriage and discusses how preimplantation genetic testing for aneuploidy (PGT-A) may help select embryos with the highest chance of success for some patients. Through real patient examples and evidence-based guidance, this episode explores the nuances of testing, timing, emotional well-being, and the ethical and financial considerations that shape decision-making. Listeners will walk away informed, empowered, and reminded that no matter their fertility path, they are not alone. In this episode you'll hear: [2:03] Why consider IVF for recurrent pregnancy loss? [4:10] IVF process & genetic testing [11:02] Real world counseling & patient scenarios [16:12] Pros & cons of IVF for recurrent pregnancy loss [24:58] Key considerations for IVF [28:15] Patient examples and recommendations [31:12] Final thoughts Dr. Shahine's Weekly Newsletter on Fertility News and Recommendations Follow @drlorashahine Instagram | YouTube | Tiktok | Her Books

If you've ever looked at your schedule and thought, “We're slammed…so why is my bank account not moving?” — this episode is going to feel like oxygen. In this PPS 2025 recap conversation, Jerry Durham sits down with Nathan Shields, founder of the Private Practice Owners Club, to break down the real reasons clinics bleed profit — and why the solution isn't more new patients. Across this episode, Nathan pulls back the curtain on the cash-flow killers hiding inside most clinics: weak collections, underperforming billing systems, inconsistent documentation, and a front desk that's unsupported (not unskilled). He also explains why AI won't fix broken processes — and why owners who skip the fundamentals end up scaling their problems, not their profit. In this episode you'll learn:The four internal “leaks” that cost clinics $100K–$300K per year — and how to close them fast.Why chasing more new patients is the wrong move when your systems are broken.The exact numbers every owner must know (and what they actually mean).How to tighten front-desk operations so patients arrive, pay, and stay.Why underbilling — not overbilling — is silently draining your margins.How AI can support your systems… but can't save you from bad processes.What PPS 2025 revealed about the future of private practice — and what owners need to fix BEFORE adding tech, growth, or new services. What you'll walk away with:A Cash-Flow Leak Audit you can run in 30 minutes.A simple 4-phase roadmap to increase revenue without increasing visits.Clarity on the 3–5 KPIs that actually drive your business (and which ones don't matter).Scripts for improving front-desk collections and reducing cancellations.A new lens for evaluating tech, platforms, and AI — so you stop wasting money and start moving the needle.

Today, Dave Furfaro, Luke Hedrick, and Robert Wharton discuss the PREDMETH trial published in The New England Journal of Medicine in 2025. This was a non-inferiority trial comparing prednisone to methotrexate for upfront therapy in treatment-naive sarcoidosis patients. Listen in for a break down of the trial, analysis, and clinically applicable pearls. Article and Reference Todays’ episode discusses the PREDMETH trial published in NEJM in 2025. Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, Koopman B, Loth DW, Nossent EJ, Wagenaar M, Kramer H, Wielders PLML, Bonta PI, Walen S, Bogaarts BAHA, Kerstens R, Overgaauw M, Veltkamp M, Wijsenbeek MS; PREDMETH Collaborators. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate. N Engl J Med. 2025 Jul 17;393(3):231-242. doi: 10.1056/NEJMoa2501443. Epub 2025 May 18. PMID: 40387020. https://www.nejm.org/doi/full/10.1056/NEJMoa2501443 Meet Our Hosts Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a first year pulmonary and critical care fellow at Johns Hopkins. Key Learning Points Clinical context Prednisone remains the traditional first-line treatment for pulmonary sarcoidosis when treatment is indicated, with evidence for short-term improvements in symptoms, radiographic findings, and pulmonary function—but with substantial, familiar steroid toxicities (weight gain, insomnia, HTN/DM, infection risk, etc.). Despite widespread use, glucocorticoids haven't been robustly tested head-to-head against many alternatives as initial therapy, and evidence for preventing long-term decline (especially in severe disease) is limited. Immunosuppressants (like methotrexate) are often used as steroid-sparing agents, but guideline recommendations are generally conditional/low-quality evidence, and practice varies. Why PREDMETH matters It addresses a real-world question: Can methotrexate be an initial alternative to prednisone in pulmonary sarcoidosis, rather than being reserved only for steroid-sparing later? It also probes a common clinical belief: MTX has slower onset than prednisone (often assumed, not well-proven). Trial design (what to know) Open-label, randomized, noninferiority trial across 17 hospitals in the Netherlands. Included patients with pulmonary sarcoidosis who had a clear pulmonary indication to start systemic therapy (moderate/severe symptoms plus objective risk features like reduced FVC/DLCO or documented decline, plus parenchymal abnormalities). Excluded: non–treatment-naïve patients and those whose primary indication was extrapulmonary disease. Treat-to-tolerability with escalation: both drugs started low and were slowly increased; switch/add-on allowed for inadequate efficacy or unacceptable side effects. Primary endpoint: change in FVC (with the usual caveat that FVC is “objective-ish,” but effort-dependent and not always patient-centered). Noninferiority margin: 5% FVC, justified as within biologic/measurement variation and “not clinically relevant.” Outcomes assessed at weeks 4, 16, 24; powered for ~110 patients to detect the NI margin. Patient population (who this applies to) Mostly middle-aged (~40s) with mild-to-moderate physiologic impairment on average (FVC ~77% predicted; DLCO ~70% predicted). Netherlands-based cohort with limited Black representation (~7%), which matters for generalizability. Would have been helpful to know more about comorbidities (e.g., diabetes), which can strongly influence prednisone risk. Main findings (what happened) Methotrexate was noninferior to prednisone at week 24 for FVC: Between-group difference in least-squares mean change at week 24: −1.17 percentage points (favoring prednisone) with CI −4.27 to +1.93, staying within the 5% NI margin. Timing mattered: Prednisone showed earlier benefit (notably by week 4) in FVC and across quality-of-life measures. By week 24, those early differences largely washed out—possibly because MTX “catches up,” and/or because crossover increased over time. In their reporting, MTX didn't meet noninferiority for FVC until week 24, supporting the practical message that prednisone works faster. Crossover and analysis nuance (important for interpretation) Crossover was fairly high, which complicates noninferiority interpretation: MTX arm: some switched to prednisone for adverse events and others had prednisone added for disease progression/persistent symptoms. Prednisone arm: some had MTX added. In noninferiority trials, heavy crossover can bias intention-to-treat analyses toward finding “no difference” (making noninferiority easier to claim). Per-protocol analyses avoid some of that but introduce other biases. They reported both. Safety signals (what to remember clinically) Adverse events were very common in both arms (almost everyone), mostly mild. Side-effect patterns fit expectations: Prednisone: more insomnia (and classic steroid issues). MTX: more headache/cough/rash, and notably liver enzyme elevations (about 1 in 4), with a small number discontinuing. Serious adverse events were rare; numbers were too small to confidently separate “signal vs noise,” but overall known risk profiles apply. Limitations (why you shouldn't over-read it) Open-label design, and FVC—while objective-ish—is still effort-dependent and can be influenced by expectation/behavior. Small trial, limiting subgroup conclusions (e.g., severity strata, different phenotypes). Generalizability issues (Netherlands demographics; US populations have higher rates of obesity/metabolic syndrome, which may tilt the steroid risk-benefit equation). Crossover reduces precision and interpretability of between-group differences over time. Practice implications (the “so what”) For many patients with pulmonary sarcoidosis needing systemic therapy, MTX is a reasonable initial alternative to prednisone when thinking long-term tolerability and steroid avoidance. Prednisone likely provides faster symptom/QoL relief in the first weeks—so it may be preferable when rapid improvement is important. The trial strengthens the case for a patient-centered discussion: short-term relief vs side-effect tradeoffs, and the possibility of early combination therapy in more severe cases (suggested, not proven).